Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 15 05 2019
revised: 04 08 2019
accepted: 14 08 2019
pubmed: 28 10 2019
medline: 18 11 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

To compare short- and long-term outcomes of patients hospitalized with non-ST-segment myocardial infarction (NSTEMI) or unstable angina (UA) who were referred for revascularization by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) in a real-world national cohort. This observational study included 5112 patients, who underwent either CABG or PCI, admitted for NSTEMI or UA and were enrolled in the Acute Coronary Syndrome Israeli Survey between 2000 and 2016. Propensity score-matching analysis compared early outcomes and all-cause mortality in patients who underwent revascularization by PCI with revascularization by CABG. Of the 5112 patients, 4327 (85%) underwent PCI and 785 (15%) CABG. Following propensity score analysis, 447 pairs were chosen (1:1). Independent predictors for CABG referral included 3-vessel CAD (odds ratio [OR], 5.5; 95% confidence interval [CI], 4.5-6.7, P < .001), absence of on-site cardiac surgery (OR, 1.3; 95% CI, 1.1-1.6, P = .004), no previous PCI (OR, 1.5; 95% CI, 1.2-1.9, P = .002) and no previous myocardial infarction (OR, 1.3; 95% CI, 1-1.7, P = .022). The 10-year mortality risk was significantly lower among those who underwent CABG compared with PCI (20.4% vs 28.4%, P = .006). Consistent with these findings, multivariable analysis showed that referral to CABG was independently associated with a significant 65% reduction in the risk of 10-year mortality (P < .001). This long-term advantage was seen among male patients (P < .001) and not female patients (P = .910). In a real-life setting, revascularization by CABG provides excellent long-term outcomes in patients with NSTEMI or UA. The advantage of CABG over PCI was seen only in male patients.

Identifiants

pubmed: 31653430
pii: S0022-5223(19)32010-0
doi: 10.1016/j.jtcvs.2019.08.130
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

926-935.e6

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Eilon Ram (E)

Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel. Electronic address: eilon.ram@sheba.health.gov.il.

Leonid Sternik (L)

Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.

Robert Klempfner (R)

Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Zaza Iakobishvili (Z)

Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Clalit Health Services, Tel Aviv, Israel.

Yael Peled (Y)

Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nir Shlomo (N)

Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ehud Raanani (E)

Department of Cardiac Surgery, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Cardiology, Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH